Por: ABC7 Health January 07, 2023
WASHINGTON -- U.S. health officials on Friday approved a closely watched Alzheimer's drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.The drug, Leqembi, is the first that's been convincingly shown to slow the decline in memory and thinking that defines Alzheimer's by targeting the disease's underlying biology. The Food and Drug... + full article
CBS News USA Health January 07, 2023
U.S. health officials on Friday approved a Alzheimer's drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.The drug, Leqembi, is the first that's been convincingly shown to... + más
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial | CNBC
FDA Approves Alzheimer's Drug That Slowed Cognitive Decline in Clinical Trial | NBC 6 South Florida
CNBC USA Health January 06, 2023
In this articleMRI image of brain showing area of Alzheimer patient.Getty ImagesThe Food and Drug Administration on Friday granted accelerated approval for the Alzheimer's drug lecanemab, the second treatment from and its Japanese partner Eisai to receive an early green... + más
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes
The Advocate USA Health January 02, 2023
What is Alzheimer’s disease?German neurologist Dr. Alois Alzheimer first identified this neurological disorder in 1906 while studying the pathology of a woman he had treated for an unusual mental illness.While examining her brain after her death, Alzheimer noticed marked... + más
How To Spot The Early Signs Of Alzheimer's | Newsweek
CNBC USA Health November 30, 2022
Alzheimer's is the most common form of dementia, a general term for loss of memory, language, and other thinking abilitiesBrian B. Bettencourt Toronto Star Getty ImagesA trial of an experimental Alzheimer's drug has been hailed as a new era in the beleaguered fight to... + más
Experimental drug appears to slow progression of Alzheimer's disease but raises safety concerns | ABC7
Forbes USA Tech October 22, 2022
A person walks on a suspended rope bridge in the clouds. Extreme attraction.getty This article is the fourth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in , , and of the series. The pharmaceutical and biotech companies, Eisai and... + más
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
Variety of factors play a role in the development of Alzheimer's | The Advocate
Newsweek USA Health September 24, 2022
The Alzheimer's Association defines Alzheimer's as a brain disease that causes a slow decline in memory, thinking and reasoning skills. Dementia refers to the symptoms of Alzheimer's that can worsen over time.They predict that by 2050, the number of people aged 65... + más
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
Portland Press Herald USA Health September 24, 2022
A study using the electronic health records of more than 6 million Americans over age 65 found that those who had COVID-19 ran a greater risk of receiving a new diagnosis of Alzheimer’s disease within a year. The study, led by researchers at Case Western Reserve University... + más
About iurex | Privacy Policy | Disclaimer |